The Wall Street Journal: Valeant Pharmaceuticals under Fed probe over drug pricing, distribution

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 14 October, 2015 by The TZ Newswire Staff

The Wall Street Journal: Valeant Pharmaceuticals under Fed probe over drug pricing, distribution

The subpoenas also seek information and documents from the Canada-based drug company regarding information it provided to the Centers for Medicare and Medicaid Services.
read more

See also
- Next Article Latest: Wal-Mart stock dives; HSBC orders pay cuts
- Previous Article Eurostoxx50 futures up +0.5% in early European trading
Editorial Calender

October 2015

M T W T F S S

1 2 3 4

5 6 7 8 9 10 11

12 13 14 15 16 17 18

19 20 21 22 23 24 25

26 27 28 29 30 31

« Sep Nov »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 14 October, 2015 by The TZ Newswire Staff

The Wall Street Journal: Valeant Pharmaceuticals under Fed probe over drug pricing, distribution

See also

Editorial Calender

Recent Tags